Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Arndt

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Substance Abuse and Rehabilitation|October 16, 2025
Sex, Race, and Ethnicity as Intersectional Predictors of Outpatient Substance Use Disorder Treatment AttritionNicholas L Bormann, Tyler S Oesterle, Mark A Lifson, et al.
Journal of Diabetes Science and Technology|September 9, 2016
Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily LifeGuido Freckmann, Stephan Arndt, Albrecht Fießelmann, et al.
Psychiatric Services (Washington, D.C.)|April 2, 2008
Barriers to care for antenatal depressionRobin Cook Kopelman, Joy Moel, Carol Mertens, et al.
Administration and Policy in Mental Health|April 5, 2011
Implementation of an evidence-based depression treatment into social service settings: the relative importance of acceptability and contextual factorsLisa S Segre, Jennifer E McCabe, Sara M Stasik, et al.
Journal of the International Neuropsychological Society : JINS|July 4, 2009
IQ estimate smackdown: comparing IQ proxy measures to the WAIS-IIIRuth Spinks, Lowell W McKirgan, Stephan Arndt, et al.
Plos One|April 11, 2017
Use of a machine learning framework to predict substance use disorder treatment successLaura Acion, Diana Kelmansky, Mark van der Laan, et al.
The American Journal of Psychiatry|July 2, 2002
Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performanceRebecca Fuller, Peg Nopoulos, Stephan Arndt, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphismDel D Miller, Vicki L Ellingrod, Timothy L Holman, et al.
Drug and Alcohol Dependence|September 6, 2024
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009-2021Christian E Johnson, George L Wehby, Elizabeth A Chrischilles, et al.
The International Journal of Eating Disorders|December 11, 2002
Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalizationVictor W Swayze, Arnold E Andersen, Nancy C Andreasen, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Substance Abuse and Rehabilitation|October 16, 2025
Sex, Race, and Ethnicity as Intersectional Predictors of Outpatient Substance Use Disorder Treatment AttritionNicholas L Bormann, Tyler S Oesterle, Mark A Lifson, et al.
Journal of Diabetes Science and Technology|September 9, 2016
Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily LifeGuido Freckmann, Stephan Arndt, Albrecht Fießelmann, et al.
Psychiatric Services (Washington, D.C.)|April 2, 2008
Barriers to care for antenatal depressionRobin Cook Kopelman, Joy Moel, Carol Mertens, et al.
Administration and Policy in Mental Health|April 5, 2011
Implementation of an evidence-based depression treatment into social service settings: the relative importance of acceptability and contextual factorsLisa S Segre, Jennifer E McCabe, Sara M Stasik, et al.
Journal of the International Neuropsychological Society : JINS|July 4, 2009
IQ estimate smackdown: comparing IQ proxy measures to the WAIS-IIIRuth Spinks, Lowell W McKirgan, Stephan Arndt, et al.
Plos One|April 11, 2017
Use of a machine learning framework to predict substance use disorder treatment successLaura Acion, Diana Kelmansky, Mark van der Laan, et al.
The American Journal of Psychiatry|July 2, 2002
Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performanceRebecca Fuller, Peg Nopoulos, Stephan Arndt, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphismDel D Miller, Vicki L Ellingrod, Timothy L Holman, et al.
Drug and Alcohol Dependence|September 6, 2024
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009-2021Christian E Johnson, George L Wehby, Elizabeth A Chrischilles, et al.
The International Journal of Eating Disorders|December 11, 2002
Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalizationVictor W Swayze, Arnold E Andersen, Nancy C Andreasen, et al.
Pageof 19